Azur Pharma is dedicated to enhancing patient's lives by developing and marketing pharmaceutical products in focused therapeutic areas. Its mission is to create a therapeutically focused pharmaceutical business, sustained through a marketed product portfolio and a product pipeline. Azur Pharma's strategy is to identify, evaluate, selectively acquire and enhance the value of FDA approved, and late-stage development, pharmaceutical assets. In June 2005, Azur Pharma completed a private placement of equity securities in an amount of EUR40 million (US$50 million).
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.